Detalhe da pesquisa
1.
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
Oncologist
; 27(6): 476-486, 2022 06 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35298662
2.
Discovery and characterization of small molecules that target the GTPase Ral.
Nature
; 515(7527): 443-7, 2014 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25219851
3.
Genomic case report of a low grade bladder tumor metastasis to lung.
BMC Urol
; 18(1): 74, 2018 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30176882
4.
CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
BMC Cancer
; 16: 713, 2016 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27595989
5.
The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
Acta Pharmacol Sin
; 36(3): 291-7, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25557115
6.
Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer.
JCO Clin Cancer Inform
; 6: e2200010, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35696627
7.
Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience.
PLoS One
; 17(8): e0264800, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35984843
8.
Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
Mol Cancer
; 10: 66, 2011 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-21619683
9.
The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells.
Mol Cancer
; 10: 82, 2011 Jul 12.
Artigo
Inglês
| MEDLINE | ID: mdl-21749705
10.
Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics.
Mol Pharm
; 8(6): 2310-9, 2011 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-22014215
11.
Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase.
Mol Cancer
; 9: 307, 2010 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-21114864
12.
RON receptor tyrosine kinase as a target for delivery of chemodrugs by antibody directed pathway for cancer cell cytotoxicity.
Mol Pharm
; 7(2): 386-97, 2010 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-20039696
13.
Potential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy.
Acta Pharmacol Sin
; 31(9): 1181-8, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20694025
14.
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth.
Oncotarget
; 9(24): 16718-16730, 2018 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-29682180
15.
Involvement of glycogen debranching enzyme in bladder cancer.
Biomed Rep
; 6(6): 595-598, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28584628
16.
Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
Clin Cancer Res
; 22(5): 1274-83, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26490312
17.
Targeting glycogen metabolism in bladder cancer.
Nat Rev Urol
; 12(7): 383-91, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26032551
18.
RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer.
Mol Cancer Res
; 13(3): 483-92, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25516960
19.
Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease.
J Natl Cancer Inst
; 106(5)2014 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-24700805
20.
Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
J Thorac Oncol
; 8(12): 1492-501, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24389431